Researchers have identified the candidate gene NR4A3 as a key molecular factor linking gut microbiota to sensorineural hearing loss, according to a multi-omics research report published in the journal AMB Express. Sensorineural hearing loss represents a widespread and prevalent auditory disorder, with acoustic noise exposure serving as its primary etiological factor, although its specific molecular mechanisms and therapeutic targets have remained poorly understood.
To uncover core target genes and clarify their physiological relationships with the gut microbiome, the investigators integrated multi-omics datasets through an extensive analytical workflow. The research team employed weighted gene co-expression network analysis, temporal analysis, Mendelian randomization, computational molecular docking, and immune infiltration analysis. Through this systematic stepwise screening strategy, the authors identified two core candidate genes, designated FOS and NR4A3.
Subsequent Mendelian randomization analysis revealed that NR4A3 was negatively associated with the relative abundance of Lachnospiraceae_NK4A136_group, yielding an odds ratio of less than one and a statistically significant P value below 0.05. According to the reported data, this specific intestinal microbe possesses potential protective biological effects within the system evaluated by the investigators.
The investigation also characterized immune dynamics across auditory conditions using dedicated immune infiltration analysis. In the noise-exposed group, the authors detected significantly increased infiltration levels of regulatory T cells, dendritic cells, and plasma cells. Statistical assessments demonstrated that these elevated immune cell populations correlated positively with the measured expression levels of both FOS and NR4A3.
To assess prospective pharmacological interactions with the target gene, the researchers performed computational screening accompanied by molecular docking and molecular dynamics simulations. These modeling analyses predicted binding affinity between NR4A3 and dexamethasone, with the computational simulations suggesting that dexamethasone forms a stable physical complex with the NR4A3 target structure.
Laboratory validation using in vitro CCK-8 cell viability assays further illuminated the cellular function of the identified candidate gene. Knockdown of NR4A3 significantly attenuated cisplatin-induced cytotoxicity across both HEI-OC1 and UB-OC1 auditory cell lines, providing experimental evidence that NR4A3 functions as a pro-damage factor during cellular auditory stress.
Furthermore, experimental exposure to heat-inactivated Lachnospiraceae_NK4A136_group partially alleviated cisplatin-induced cell death in the evaluated models. Notably, this protective influence was largely abrogated upon NR4A3 knockdown, demonstrating that the otoprotective effect of the bacterium remains dependent on NR4A3. Collectively, the authors concluded that NR4A3 may drive the pathogenesis of sensorineural hearing loss through direct cellular damage and indirect suppression of protective gut microbiota, representing a candidate target for future disease intervention.
Subject of Research: Molecular mechanisms linking NR4A3, gut microbiota, and sensorineural hearing loss
Article Title: Transcriptome-guided identification of NR4A3 as a candidate gene linking gut microbiota and sensorineural hearing loss
Article References: Li, S., Zhou, C., & Zhang, Q. (2026). Transcriptome-guided identification of NR4A3 as a candidate gene linking gut microbiota and sensorineural hearing loss. AMB Express. https://doi.org/10.1186/s13568-026-02136-z
Image Credits: AI Generated
DOI: 10.1186/s13568-026-02136-z
Keywords: sensorineural hearing loss, NR4A3, gut microbiota, FOS, Lachnospiraceae_NK4A136_group, Mendelian randomization, immune infiltration, regulatory T cells, dendritic cells, plasma cells, molecular docking, molecular dynamics, dexamethasone, HEI-OC1, UB-OC1, cisplatin cytotoxicity, WGCNA, otoprotection
News Source: Morgan Morrow. (November 19, 2026). Study Identifies NR4A3 Gene Linking Gut Microbiome to Sensorineural Hearing Loss. Scienmag.



